15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering Biohaven Ltd, 9 rate it Buy or better, 4 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $9.00 to $75.00 (about 8.3x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $25.85 sits 78% above the current $14.52. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.57 next quarter toward $-1.95 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Moderate Buy
Strong Buy17%
Buy857%
Hold429%
Sell17%
Strong Sell00%
Based on 14 analysts giving stock ratings to Biohaven Ltd.
As of Jul, 9 of 14 firms rate BHVN a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
BHVN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.57
Range $-0.74 – $-0.45 · 7 analysts · -61% YoY
Next period, 7 analysts expect Biohaven Ltd. to earn $-0.57 a share (range $-0.74 – $-0.45), versus $-1.47 a year earlier. Full-year consensus is $-2.40, growing to $-1.95 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 7 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $21.4M next year.
Top analysts covering Biohaven Ltd.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BHVN.
#1
Leonid Timashev
RBC Capital · Rank #69
Buy
$22.00+51.6% to target
Overall win rate
42%
+ Follow
#2
Jason Gerberry
B of A Securities · Rank #136
Sell
$11.00-24.2% to target
Overall win rate
46%
+ Follow
#3
Charles Duncan
Cantor Fitzgerald · Rank #188
Buy
No targeton BHVN
Overall win rate
42%
+ Follow
#4
Douglas Tsao
HC Wainwright & Co. · Rank #212
Hold
$10.00-31.1% to target
Overall win rate
35%
+ Follow
#5
Sumant Kulkarni
Canaccord Genuity · Rank #278
Buy
$21.00+44.7% to target
Overall win rate
39%
+ Follow
BHVN stock forecast FAQ
What is BHVN's average 12-month price target?+
The 13 analysts with a live target average $25.85 for Biohaven Ltd. over the next 12 months, ranging from a $75.00 high to a $9.00 low.
Is BHVN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 14 analyst ratings, 9 are Buy or Strong Buy, 4 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for BHVN?+
The Street-high target is $75.00 (Raymond James), and the Street-low is $9.00 (Bernstein). The average of all 13 active targets is $25.85.
How many Wall Street analysts cover BHVN?+
14 analysts have an active rating on Biohaven Ltd., and 13 firms carry a live 12-month price target.
Who is the most accurate analyst covering BHVN?+
Among analysts who currently cover BHVN, Leonid Timashev of RBC Capital has the strongest overall Quantellect track record (Rank #69). Their current call is Buy with a $22.00 target.
What is Biohaven Ltd.'s projected EPS for next quarter?+
The consensus estimate is $-0.57 per share (range $-0.74 – $-0.45) across 7 analysts. Full-year EPS is projected at $-2.40, rising to $-1.95 the following year.
How much revenue is Biohaven Ltd. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $21.4M next year.
Have analysts been upgrading or downgrading BHVN lately?+
As of Jul, 9 of 14 firms rate BHVN a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BHVN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
